SBC Medical Group Holdings Inc 8-K

What Happened

• SBC Medical Group Holdings Inc. announced a transaction via a press release dated January 5, 2026 and furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K (Items 7.01 and 8.01). The company also posted an investor presentation about the transaction on its website (https://sbc-holdings.com/en/ir/ir-presentation). The Form 8-K was signed by Chief Financial Officer Yuya Yoshida on January 5, 2026.

Key Details

• Press release announcing the transaction was issued and furnished as Exhibit 99.1 on January 5, 2026.
• Investor presentation about the transaction was posted to the company’s IR website: https://sbc-holdings.com/en/ir/ir-presentation.
• The filing includes a Regulation FD disclosure (Item 7.01) noting the press release, and a website disclosure (Item 8.01) stating the company may post material information online and offers email alerts to investors.
• The report was signed by Yuya Yoshida, Chief Financial Officer, on January 5, 2026.

Why It Matters

• This Form 8-K formally notifies investors that SBC issued public materials about a transaction and made supporting presentation materials available — these documents may contain material information investors should review. The filing does not itself include transaction terms or financial details beyond the released materials, so investors should read the furnished press release and the posted presentation for the specific facts and any potential financial impact.